ASH - Ashland Q3 -Adj. EPS $1.02 vs est $0.98 -Sales $497.000M vs est $485.979M -"Ashland’s third-quarter results reflected broad-based dema
ASH - Ashland Q3 -Adj. EPS $1.02 vs est $0.98 -Sales $497.000M vs est $485.979M -"Ashland’s third-quarter results reflected broad-based demand and strong commercial execution across the portfolio," said Guillermo Novo, chair and Chief Executive Officer, Ashland. "Sales increased seven percent year-over-year, with growth achieved across all business units and regions. Our teams continued to successfully recover higher raw material costs through pricing actions, preserving margins while maintaining strong customer relationships. Life Sciences delivered double-digit sales gains, benefiting from broad demand across Pharma and continued progress from our globalize and innovate strategies. Personal Care generated another quarter of strong performance, led by momentum in biofunctional actives, high-single-digit growth in skin Care, and favorable contributions from hair Care and microbial Protection. Specialty Additives benefited from continued growth in coatings and performance specialties driven by share gains and strong commercial momentum. In Intermediates, merchant sales increased, reflecting improving Nmp demand for Battery-related applications."
ASH - Ashland Q3 -Adj.
EPS $1.02 vs est $0.98 -Sales $497.000M vs est $485.979M -"Ashland’s third-quarter results reflected broad-based demand and strong commercial execution across the portfolio," said Guillermo Novo, chair and Chief Executive Officer, Ashland. "Sales increased seven percent year-over-year, with growth achieved across all business units and regions.
Our teams continued to successfully recover higher raw material costs through pricing actions, preserving margins while maintaining strong customer relationships.
Life Sciences delivered double-digit sales gains, benefiting from broad demand across Pharma and continued progress from our globalize and innovate strategies.
Personal Care generated another quarter of strong performance, led by momentum in biofunctional actives, high-single-digit growth in skin Care, and favorable contributions from hair Care and microbial Protection.
Specialty Additives benefited from continued growth in coatings and performance specialties driven by share gains and strong commercial momentum.
In Intermediates, merchant sales increased, reflecting improving Nmp demand for Battery-related applications."